L-Arginine-L-pyroglutamate
CAS: 56265-06-6
Ref. 3D-FA39360
| 1g | Descontinuado | ||
| 2g | Descontinuado | ||
| 5g | Descontinuado | ||
| 10g | Descontinuado | ||
| 25g | Descontinuado |
Informação sobre produto
Nome:
L-Arginine-L-pyroglutamate
Sinónimos:
- <span class="text-smallcaps">L</smallcap>-Arginine, compd. with 5-oxo-<smallcap>L</span>-proline (1:1)
- <span class="text-smallcaps">L</smallcap>-Proline, 5-oxo-, compd. with <smallcap>L</span>-arginine (1:1)
- Arg-Pyr
- Arginine PCA
- Arginine pyroglutamate
- L-Arg L-Pyr
- L-Arginine L-Pyroglutamic acid
- L-Arginine Pyroglutamate
- N~5~-(diaminomethylidene)-L-ornithine-5-oxo-L-proline (1:1)
Descrição:
L-Arginine-L-pyroglutamate is a basic protein that is synthesized from L-arginine and pyroglutamic acid. It has chemotactic activity, meaning that it can cause cells to migrate towards the compound. L-Arginine-L-pyroglutamate has been shown to have protease activity against a number of tissue proteins, including collagenases and elastases. The expression plasmid containing the gene for this protein was used to diagnose squamous cell carcinoma in women as well as cervical cancer in mice. The use of L-Arginine-L-pyroglutamate in prognosis and diagnosis of hyperproliferative diseases such as skin cancer may be a promising area for future research.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
